Elicera Therapeutics AB (publ) (FRA:8E8)
Germany · Delayed Price · Currency is EUR 0.4495
-0.0030 (-0.66%)
At close: Jan 5, 2026
Elicera Therapeutics AB Market Cap
Elicera Therapeutics AB has a market cap or net worth of €26.81 million as of January 9, 2026. Its market cap has increased by 394.63% in one year.
Market Cap
26.81M
Enterprise Value
23.55M
Revenue
1.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.45
Market Cap Chart
Since June 11, 2021, Elicera Therapeutics AB's market cap has increased from 12.18M to 26.81M, an increase of 120.09%. That is a compound annual growth rate of 18.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 26.81M | 14.40% |
| Dec 30, 2025 | 23.43M | 358.22% |
| Dec 30, 2024 | 5.11M | -36.80% |
| Dec 29, 2023 | 8.09M | 29.64% |
| Dec 30, 2022 | 6.24M | -35.63% |
| Dec 30, 2021 | 9.70M | -20.40% |
| Jun 11, 2021 | 12.18M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 247.30B |
| Siemens Aktiengesellschaft | 197.59B |
| Allianz SE | 145.37B |
| Deutsche Telekom AG | 134.99B |
| Siemens Energy AG | 107.65B |
| Rheinmetall AG | 87.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.47B |
| Deutsche Bank Aktiengesellschaft | 63.02B |